News & analysis on the clinical development and manufacture of large molecule drugs
Atara Biotherapeutics, Maria Roncarolo
By Ben Hargreaves
- Last updated on
Atara Biotherapeutics appoints Maria Roncarolo to its board of directors. According to the biotech, Roncarolo is an expert of immunology, as well as in regard to cell and gene therapies.
Roncarolo is the co-director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. In the position, she leads efforts to create stem cell therapies and gene therapies, based on discoveries made at the university.
As part of her prior research, she contributed to the discovery of novel cytokines and studied how these can induce immunological tolerance, as well as promoting stem cell growth and differentiation.
“I am thrilled to have one of the world’s leading experts in immunology and T cells, Roncarolo, bringing to our board her experience and strategic vision in cell therapy and gene editing as well as her passion for transformative immunotherapies,” said Pascal Touchon, CEO of Atara.